Search results for "STELLA"

showing 10 items of 1995 documents

Contribución al conocimiento de los murciélagos (Mammalia, Chiroptera) del Parque Natural de Penyagolosa (provincia de Castellón)

2019

Se exponen los principales resultados obtenidos en los muestreos efectuados en agosto de 2004 en el Parque Natural de Penyagolosa. La comunidad de quirópteros del Parque Natural está integrada por al menos 14 especies. Diez de ellas fueron localizadas en los muestreos, siendo ocho nuevas citas tras ellos. La revisión de la bibliografía e informes técnicos más recientes permiten añadir las restantes cuatro especies. De entre las especies localizadas en los muestreos, destacan las forestales Plecotus auritus (Linnaeus, 1758) y Barbastella barbastellus (Schreber, 1774); las fisurícolas Pipistrellus pipistrellus (Schreber, 1774) y Eptesicus serotinus (Schreber, 1774) y la cavernícola Myotis esc…

0106 biological sciencesMyotis escaleraiespañachiropteraPopulationContext (language use)010603 evolutionary biology01 natural sciencespenyagolosaEptesicus serotinusPipistrellus pipistrelluseducationEcology Evolution Behavior and Systematicseducation.field_of_studybiologyEcologycastellón010604 marine biology & hydrobiologydistribuciónRestricted distributionbiology.organism_classificationBarbastella barbastellusGeographyQL1-991Plecotus auritusAnimal Science and ZoologyZoologyGraellsia
researchProduct

Giant, unconventional anomalous Hall effect in the metallic frustrated magnet candidate, KV 3 Sb 5

2020

The anomalous Hall effect soars when Dirac quasiparticles meet frustrated magnetism.

02 engineering and technology01 natural sciencesCondensed Matter::Materials ScienceHall effectCondensed Matter::Superconductivity0103 physical sciencesAstrophysics::Solar and Stellar Astrophysics010306 general physicsAstrophysics::Galaxy AstrophysicsResearch ArticlesPhysicsMultidisciplinaryCondensed matter physicsScatteringDirac (video compression format)PhysicsSciAdv r-articles021001 nanoscience & nanotechnologyCondensed Matter::Mesoscopic Systems and Quantum Hall EffectSemimetalFerromagnetismMagnetQuasiparticleSpin Hall effectCondensed Matter::Strongly Correlated Electrons0210 nano-technologyResearch ArticleScience Advances
researchProduct

Impact of accumulated dust particles' charge on the photovoltaic module performance

2016

Abstract This work is focused on analysing effect of accumulated dust particles' charge on PV module performance. In the Dundee University's laboratory, dust particles have been created through epoxy powder and charged by using corona and tribo-electric charging methods by varying the charge levels of the accumulated dust particles. The PV module output has analysed for finding a relation between charge levels of the accumulated dust particles and its output voltage. Obtained experimental results have shown that charge level of accumulated dust particles on PV module's have significant impact on its output and dust particle accumulations are not associated with panel tilt angle.

020209 energyDust particlesAstrophysics::Cosmology and Extragalactic Astrophysics02 engineering and technology010501 environmental sciencescomplex mixtures01 natural sciencesCorona (optical phenomenon)0202 electrical engineering electronic engineering information engineeringAstrophysics::Solar and Stellar AstrophysicsElectrical and Electronic EngineeringAstrophysics::Galaxy Astrophysics0105 earth and related environmental sciencesPhysicsbusiness.industryPhotovoltaic systemElectrical engineeringCharge (physics)Condensed Matter PhysicsElectrostaticsrespiratory tract diseasesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsComputational physicsParticleAstrophysics::Earth and Planetary AstrophysicsbusinessBiotechnologyVoltageJournal of Electrostatics
researchProduct

HGF/MET Axis Induces Tumor Secretion of Tenascin-C and Promotes Stromal Rewiring in Pancreatic Cancer

2021

Simple Summary It has been previously shown that activation of the MET receptor by its ligand, the hepatocyte growth factor (HGF), modulates the tumor-stroma cross-talk in models of pancreatic cancer. We now wish to cast light on the molecular mechanisms by which this ligand/receptor pair sustains the interaction between cancer cells and the tumor microenviroment. To this end, we compared data obtained by large-scale analysis of gene expression in pancreatic cancer cells grown in the presence of HGF versus cells grown in the presence of HGF and treated with specific inhibitors of HGF/MET signaling. By clustering differentially expressed genes according to functional groups, we identified ca…

0301 basic medicineCancer ResearchStromal cellpancreatic ductal adenocarcinomaArticle03 medical and health sciences0302 clinical medicinePancreatic tumorPancreatic cancerMET oncogenemedicinetumor microenvironmentmetastasisHepatocyte growth factor; MET oncogene; Metastasis; Pancreatic ductal adenocarcinoma; Tenascin C; Tumor microenvironmentRC254-282Tumor microenvironmentbiologyChemistryTenascin Ctenascin CNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.disease030104 developmental biologyhepatocyte growth factorOncology030220 oncology & carcinogenesisCancer cellHepatic stellate cellbiology.proteinCancer researchHepatocyte growth factormedicine.drugCancers
researchProduct

Cytotoxic effects induced by patulin, deoxynivalenol and toxin T2 individually and in combination in hepatic cells (HepG2).

2018

Abstract Patulin (PAT), deoxynivalenol (DON) and toxin T-2 (T-2) are mycotoxins distributed worldwide in food and feed. Cytotoxicity of the three mycotoxins individually or in combination in human hepatocellular carcinoma (HepG2) cells was evaluated by MTT assay over 24, 48 and 72 h of exposure. The concentration ranges used were 0.625–15 μM for DON, 1.25–50 nM for T-2 and 0.45–7.5 μM for PAT. The IC 50 values obtained ranged from 9.30 to 2.53 μM, from 33.69 to 44.37 nM and from 2.66 to 1.17 μM for DON, T-2 and PAT, respectively. The most cytotoxic mycotoxin to HepG2 cells was T-2 followed by PAT and DON. The combination ratios used for the mixtures were 1:3 (DON: T-2), 1:5 (DON: PAT), 1:1.…

0301 basic medicineCell SurvivalComplex MixturesToxicologymedicine.disease_causePatulin03 medical and health scienceschemistry.chemical_compoundInhibitory Concentration 500404 agricultural biotechnologymedicineCytotoxic T cellHumansMTT assayDrug InteractionsCytotoxicityMycotoxinDose-Response Relationship DrugToxin04 agricultural and veterinary sciencesGeneral MedicineHep G2 CellsMycotoxinsmedicine.disease040401 food scienceMolecular biologyDrug CombinationsT-2 Toxin030104 developmental biologyPatulinchemistryLiverHepatocellular carcinomaHepatic stellate cellTrichothecenesFood ScienceFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association
researchProduct

Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells

2017

AbstractWe have used a computational approach to identify anti-fibrotic therapies by querying a transcriptome. A transcriptome signature of activated hepatic stellate cells (HSCs), the primary collagen-secreting cell in liver, and queried against a transcriptomic database that quantifies changes in gene expression in response to 1,309 FDA-approved drugs and bioactives (CMap). The flavonoid apigenin was among 9 top-ranked compounds predicted to have anti-fibrotic activity; indeed, apigenin dose-dependently reduced collagen I in the human HSC line, TWNT-4. To identify proteins mediating apigenin’s effect, we next overlapped a 122-gene signature unique to HSCs with a list of 160 genes encoding…

0301 basic medicineCirrhosisCellPharmacologyBiologyArticleCell LineTranscriptome03 medical and health scienceschemistry.chemical_compoundMiceDrug DiscoverymedicineHepatic Stellate CellsAnimalsHumansApigeninMultidisciplinaryDrug Repositioningmedicine.diseaseHepatic stellate cell activationAntifibrinolytic Agents3. Good health030104 developmental biologymedicine.anatomical_structurechemistryCell cultureApigeninHepatic stellate cellHepatic fibrosisTranscriptomeBiomarkersScientific Reports
researchProduct

2018

Abstract Chronic hepatitis leads to liver fibrosis and cirrhosis. Cirrhosis is a major cause of worldwide morbidity and mortality. Macrophages play a key role in fibrosis progression and reversal. However, the signals that determine fibrogenic vs fibrolytic macrophage function remain ill defined. We studied the role of interleukin-4 receptor α (IL-4Rα), a potential central switch of macrophage polarization, in liver fibrosis progression and reversal. We demonstrate that inflammatory monocyte infiltration and liver fibrogenesis were suppressed in general IL-4Rα−/− as well as in macrophage-specific IL-4Rα−/− (IL-4RαΔLysM) mice. However, with deletion of IL-4RαΔLysM spontaneous fibrosis revers…

0301 basic medicineCirrhosisbusiness.industryMacrophage polarizationInflammationCCL4General MedicineCCL2medicine.diseaseGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences030104 developmental biologyFibrosisHepatic stellate cellCancer researchmedicineTumor necrosis factor alphamedicine.symptombusinessEBioMedicine
researchProduct

A Multi-Parametric Fluorescent Assay for the Screening and Mechanistic Study of Drug-Induced Steatosis in Liver Cells in Culture.

2017

Human hepatic cells have been used for drug safety risk evaluations throughout early development phases. They provide rapid, cost-effective early feedback to identify drug candidates with potential hepatotoxicity. This unit presents a cell-based assay to evaluate the risk of liver damage associated with steatogenic drugs. Detailed protocols for cell exposure to test compounds and for the assessment of steatosis-related cell parameters (intracellular lipid content, reactive oxygen species production, mitochondrial impairment, and cell death) are provided. A few representative results that illustrate the utility of this procedure for the screening of drug-induced steatosis are shown. © 2017 b…

0301 basic medicineDrugProgrammed cell deathmedia_common.quotation_subjectCellMitochondria LiverBiologyToxicology03 medical and health sciencesmedicineHumansCells Culturedmedia_commonchemistry.chemical_classificationReactive oxygen speciesCell Deathmedicine.diseaseLipid MetabolismFatty Liver030104 developmental biologymedicine.anatomical_structurechemistryBiochemistryLiverHigh-content screeningCancer researchHepatic stellate cellHepatocytesSteatosisChemical and Drug Induced Liver InjuryReactive Oxygen SpeciesIntracellularCurrent protocols in toxicologyLiterature Cited
researchProduct

Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites

2017

Advances in organ-on-chip technologies for the application in in vitro drug development provide an attractive alternative approach to replace ethically controversial animal testing and to establish a basis for accelerated drug development. In recent years, various chip-based tissue culture systems have been developed, which are mostly optimized for cultivation of one single cell type or organoid structure and lack the representation of multi organ interactions. Here we present an optimized microfluidic chip design consisting of interconnected compartments, which provides the possibility to mimic the exchange between different organ specific cell types and enables to study interdependent cel…

0301 basic medicineKidneyCell typeBiomedical Engineering02 engineering and technologyComputational biologyBiology021001 nanoscience & nanotechnologyBiomaterials03 medical and health sciencesTissue culture030104 developmental biologymedicine.anatomical_structureDrug developmentToxicityHepatic stellate cellOrganoidmedicine0210 nano-technologyDrug metabolismBiomedical engineeringACS Biomaterials Science & Engineering
researchProduct

Determinants of fibrosis progression and regression in NASH

2017

Cirrhosis has become the major liver-related clinical endpoint in non-alcoholic steatohepatitis (NASH). However, progression to cirrhosis is less predictable in NASH than in other chronic liver diseases. This is due to the complex and multifactorial aetiology of NASH, which is determined by lifestyle and nutrition, multiple genetic and epigenetic factors, and a prominent role of hepatic and extrahepatic comorbidities. Thus, modest changes in these cofactors can also induce fibrosis regression, at least in patients with precirrhotic liver disease. Fibrogenesis in NASH correlates with, but is indirectly coupled to, classical inflammation, since fibrosis progression is driven by repetitive per…

0301 basic medicineLiver CirrhosisCirrhosisInflammationBioinformaticsCholangiocyte03 medical and health sciencesLiver disease0302 clinical medicineFibrosisNon-alcoholic Fatty Liver DiseaseClinical endpointMedicineHumansHepatologybusiness.industryDisease Managementmedicine.diseasePrognosis3. Good health030104 developmental biologyImmunologyHepatic stellate cellDisease Progression030211 gastroenterology & hepatologySteatohepatitismedicine.symptombusinessJournal of Hepatology
researchProduct